Journal ArticleDOI
The Added Role of MR Imaging in Treatment Stratification of Patients with Gynecologic Malignancies: What the Radiologist Needs to Know
TLDR
The purpose of this review is to highlight the added role of MR imaging in the treatment stratification and overall care of patients with endometrial, cervical, or ovarian cancer.Abstract:
Advances in MR imaging techniques, along with the growing role of the radiologist as part of a multidisciplinary treatment-planning team, have become central in tailoring treatment options and frequently lead to modifications in the therapeutic approach in patients with gynecologic malignancies.read more
Citations
More filters
Journal ArticleDOI
Metastatic gynecologic malignancies: advances in treatment and management
TL;DR: The biology of gynecologic cancer metastasis is examined and new treatment options for these cancers are focused on with a focus on ovarian cancer.
Journal ArticleDOI
Contemporary management of uterine clear cell carcinoma: A Society of Gynecologic Oncology (SGO) review and recommendation
TL;DR: This SGO review is updated with all relevant, published information since 2009 considered clinically important for management of UCCC, and follows the new SGO's style for this type of publication which includes utilization of the question and answer format.
Journal ArticleDOI
Diagnostic Performance of MRI for Assessing Parametrial Invasion in Cervical Cancer: A Head-to-Head Comparison between Oblique and True Axial T2-Weighted Images.
Sungmin Woo,Min Hoan Moon,Jeong Yeon Cho,Jeong Yeon Cho,Seung Hyup Kim,Seung Hyup Kim,Sang Youn Kim +6 more
TL;DR: O oblique axial T2WI potentially provides greater diagnostic performance than true axialT2WI for determining PMI, particularly for tumors > 2.5 cm.
Journal ArticleDOI
Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes
Levent Mutlu,Diego D Manavella,G. Gullo,Blair McNamara,Alessandro D. Santin,Pasquale Patrizio +5 more
TL;DR: Management of endometrial cancer in young women who desire to maintain fertility presents a unique set of challenges since the standard surgical treatment based on hysterectomy and salpingo-oophorectomy is often not compatible with the patient's goals.
Journal ArticleDOI
Synergism of spectra averaging and extrapolation for quantification of in vivo MRS time signals encoded from the ovary
TL;DR: In this paper, the fast Pade transform (FPT) is further optimized for encoded in vivo MRS time signals, which is achieved by a judicious combination of spectra averaging and time signal extrapolation.
References
More filters
Journal ArticleDOI
Cancer statistics, 2010
TL;DR: The American Cancer Society as mentioned in this paper estimated the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data regarding cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data from National Center for Health Statistics.
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology
DG Pfister,K. K. Ang,D Brizel +2 more
Journal ArticleDOI
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote,Claes G. Tropé,Frédéric Amant,G.B. Kristensen,Tom Ehlen,N Johnson,René H.M. Verheijen,Maria E. L. van der Burg,A. J. Lacave,Pierluigi Benedetti Panici,Gemma G. Kenter,Antonio Casado,Cesar Mendiola,Corneel Coens,Leen Verleye,Gavin Stuart,Sergio Pecorelli,Nicholas Reed +17 more
TL;DR: Neoadjuvant chemotherapy followed by interval debulking surgery was not inferior to primary debulked surgery followed by chemotherapy as a treatment option for patients with bulky stage IIIC or IV ovarian carcinoma in this study.
Journal ArticleDOI
Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
Anwar R. Padhani,Guoying Liu,Dow Mu-Koh,Thomas L. Chenevert,Harriet C. Thoeny,Taro Takahara,Andrew Dzik-Jurasz,Brian D. Ross,Marc Van Cauteren,David J. Collins,Dima A. Hammoud,Gordon J. S. Rustin,Bachir Taouli,Peter L. Choyke +13 more
TL;DR: DW-MRI should be tested as an imaging biomarker in the context of well-defined clinical trials, by adding DW-MRI to existing NCI-sponsored trials, particularly those with tissue sampling or survival indicators, and standards for measurement, analysis, and display are needed.